M

Question

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Total Forecasters45
Community Prediction4%

Make a Prediction

50%
community: 4%
median 4.0%mean 7.0%
0%10%20%30%40%50%60%70%80%90%100%
Authors:
Opened:
Closes:
Scheduled resolution:

Comments

? comments